ONCOLife Issues
Featured Articles
Trending Articles
Reprogramming Cancer Cell Death: A New Immune-Based Strategy for Blood Cancers
ONCOLife | 12 October 2025
In Vivo CAR T on the Horizon: BMS Acquires Orbital to Expand Cell Therapy Reach
Pharma | 10 October 2025
AstraZeneca makes deal with Trump Admin to Cut Drug Prices 80% and Invest $50B in US
Pharma | 11 October 2025
FDA Approves Libtayo as First Adjuvant Immunotherapy for High-Risk CS Cell Carcinoma
FDA & EMA | 9 October 2025
Datroway Improves Survival in First-Line Treatment of Metastatic Triple- Breast Cancer
ONCOLife | 6 October 2025
FDA Approves Tecentriq–Zepzelca Combo as FL Maintenance Therapy for ES-SC Lung Cancer
FDA & EMA | 3 October 2025
Dr. Eleni Lagkadinou Discusses How AbbVie Is Advancing Targeted Innovation for HT Cancers
ONCOLife | 1 October 2025
FDA Approves Imlunestrant for ESR1-Mutated Metastatic Breast Cancer
FDA & EMA | 27 September 2025
DESTINY-Breast05: Enhertu Outperforms T-DM1 in High-Risk HER2+ Early Breast Cancer
FDA & EMA | 1 October 2025
Giredestrant Plus Everolimus Improves PF Survival in ER+ Advanced Breast Cancer
ONCOLife | 26 September 2025
The V Foundation and CVC Collaborate to Advance Breast Cancer Vaccine Research
ONCOLife | 12 September 2025
NEJM Study Confirms Low-Dose Aspirin Halves Recurrence in Colorectal Cancer
Clinical Trials | 20 September 2025
EMA’s CHMP Backs Subcutaneous Pembrolizumab in Head and Neck Cancer
FDA & EMA | 19 September 2025
Climate-Driven Health Risks to Put $1.5 Trillion in Productivity at Stake by 2050
Opinion
18 September 2025
The Role of Third-Generation TKIs in Overcoming Chronic Myeloid Leukemia Resistance
ONCOLife
17 September 2025
SUNMO Trial: A New Chapter for Transplant-Ineligible Large B-Cell Lymphoma
ONCOLife
15 September 2025
CVC and V Foundation Fuel $500K Grant for Next Phase of Breast Cancer Vaccine Research
ONCOLife
10 September 2025
The Integration of START and CURC Could Play a Pivotal Role in Advancing Clinical Trials
ONCOLife
20 June 2025
The V Foundation for Cancer Research and CVC Partner to Accelerate Breast Cancer Vaccines
ONCOLife
29 August 2025
The First FDA-Cleared Blood Test for Alzheimer’s Diagnosis Now Available on the Market
Neurology
19 August 2025
First Patient Enrolled for Aliya® PEF Tumor Ablation of Lung/Liver Soft-Tissue Lesions
ONCOLife
18 August 2025
Ferroptosis as a New Strategy: Iron-Driven Cell Death Targets Cancer Stem Cells
ONCOLife
17 August 2025
Redesigned CD40 Antibody Triggers Systemic Tumor Regression and Complete Remission
ONCOLife
15 August 2025